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  In this case report, we present a mock-transduced bone 
marrow  (BM)  transplantation  in  a  mouse,  which  was 
found moribund and autopsied to evaluate pathogenesis. 
Macroscopically, red discoloration of systemic organs was 
observed.  Hematological  values  revealed  a  decrease  in 
white blood cells, red blood cells, hematocrit, hemoglobin, 
and  platelets,  but  an  increase  in  reticulocytes.  In  BM 
cytology, hematopoietic cell lines were severely depleted. 
Histopathologically,  hemorrhage  in  the  cerebellar 
parenchyma, hemosiderin deposition and hemorrhage in 
the heart, necrosis and telangiectasia in liver, pulmonary 
parenchymal  cysts,  spermatogenic  germ  cells  necrosis, 
atrophy  and  hemorrhage  in  testis,  oligospermia  and 
hemorrhage in the epididymis, and atrophy of BM, thymus 
and spleen were observed. In conclusion, autoimmune-like 
complications  such  as  hematological  value  change,  BM 
dysplasia and systemic hemorrhage appear to be the lethal 
cause  of  the  mouse  transplanted  with  mock-transduced 
BM. 
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Gene therapy with allogeneic or autologous bone marrow 
(BM) cells transduced with the normal gene sequence 
expressing the missing protein (s) comprises an attractive 
treatment for inherited hematological, non-hematological, 
and immunological defects [3,10]. Some viral vectors such 
as retroviral gene transfer [13] have been employed to 
transfer genes as well as BM transplantation (BMT) by 
many investigators [7]. Autoimmune-like complication 
after BMT leads morphological and functional changes of 
target tissues [9]. Some previous studies demonstrated that 
central nervous system (CNS), thymus, skin, liver, 
gastrointestinal tract, gonads, and heart are targeted in 
autoimmune-like complication [1,4,5,16]. However, reports 
dealing with the pathological features of BMT related- 
toxicity are limited. 
In the present study, we report the histopathological 
features, hematological values, and BM cytology of a 
mouse transplanted with mock-transduced bone marrow, 
which was found moribund.
The carcinogenic effects of BMT with gene transduced 
BM via retroviral vector in a C57BL/6 male mouse was 
presented. The mouse was irradiated at 7.5 Gy from a Cs
137 
source. Transplanted BM cells were originally enriched 
hematopoietic stem cells isolated from the C57BL/6 male 
mouse and were transfected with the mock viral vector 
(empty particle) without any transgene. The tranduced BM 
cells were administered by tail vein injection at a dose of 
35 × 10
6 cells/kg body weight. Total experimental period 
was 53 days, but the mouse was found moribund 19 days 
after BMT and autopsied to evaluate its pathogenesis. 
Selected hematology, histopathology, and bone marrow 
cytology measures were evaluated.
Hematological values (Table 1) revealed a decrease in the 
white blood cells (WBC), red blood cells (RBC), hematocrit, 
hemoglobin, and platelets, but an increase in reticulocytes. 
In BM cytology, a small number of erythroid cells, 
plasma cells, macrophages, lymphoblasts, lymphocytes 
etc, were observed, but myeloid cells were almost completely 
depleted (Fig. 1, Table 2).
In the autopsy findings, red discoloration of subcutaneous, 
cerebellum, lymph nodes (submandibular and mesenteric), 
testis, epididymis and gastrointestinal tract were observed. 
Enlargement of the gall bladder was also noted.
Histopathologically, a severe hemorrhage was seen in 
cerebellar parenchyma (Fig. 2A). Pulmonary parenchymal 
cysts were also observed in the lung (Fig. 2B). Hemosiderin 
deposition, hemorrhage in the heart (Fig. 2C), hepatocellular 
necrosis and telangiectasia in liver (Fig. 2D) were also 
detected. Furthermore, hemorrhage and atrophy of 362    Yong-Hoon Kim et al.
Table 1. Hematological values of the mouse found moribund 19 
days after bone marrow transplantation
Items Case values Control values*
White blood cell (×10
3/μL) 0.34 3.08 ± 0.25
Red blood cell (×10
6/μL) 1.39 10.80 ± 0.21
Hemoglobin (g/dL) 2.50 15.54 ± 0.27
Hematocrit (%) 10.30 50.19 ± 0.81
Platelet (×10
3/μL) 17.00 1053.11 ± 58.29
Reticulocyte (%) 30.90 3.64 ± 0.16
*Data at 53 days after bone marrow transplantation, mean ± SD (n = 9).
Fig. 1. Bone marrow (BM) cytology from the mouse found 
moribund 19 days after BM transplantation (BMT). BM 
cytology showed a severe loss of hematopoietic cells. (A) Few 
basophilic erythroblasts, basophils, macrophages, plasma cells, 
and lymphoblasts. (B) Proerythroblasts, polychromatic erythro-
blasts, and lymphocytes are present. Wright-Geimsa stain.
Table 2. Bone marrow cytology values of the mouse found 
moribund 19 days after bone marrow transplantation
Items Case values  Control values*
Myeloid cell/Erytheroblast ratio 0.00 1.16 ± 0.09
Total erythroid cell (%) 13.94 35.42 ± 2.30
Proerythroblast (%) 0.00 0.35 ± 0.10
Basophilic erythroblast (%) 0.00 0.51 ± 0.14
Polychromatic erythroblast (%) 13.94 34.56 ± 2.26
Total myeloid cell (%) 0.00 3.64 ± 0.16
*Data at 53 days after bone marrow transplantation, mean ± SD (n = 9).
Fig. 2. Histopathological changes of the mouse found 
moribund 19 days after BMT. (A) Infiltration of large number of
red blood cells is seen in the cerebellar parenchyma. (B) Cysts are
seen in the pulmonary parenchyma. (C) Hemosiderin deposition
is seen in heart myocytes. (D) Hepatocellular necrosis and dilated
sinusoid are seen in the liver. (E, F) Hemorrhage in the testicular
interstitial space, atrophy of seminiferous tubules, and necrosis 
of spermatogenic germ cells are noted. H&E stain.
seminiferous tubules with necrosis of spermatogenic germ 
cells were noted in the testis (Figs. 2E and F). Oligospermia 
and hemorrhage in the epididymis, and atrophy of the BM, 
thymus, and spleen were observed. 
The first successful allogeneic BMT in human was 
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been used with increasing frequency for the treatment of 
malignant and nonmalignant hematologic diseases, solid 
tumors, and metabolic and genetic diseases [5]. However, 
precise regulation of therapeutic gene expression in vivo is 
still a challenge and the specificity and safety gene therapy 
needs to be improved even further [13]. Autoimmune-like 
complication represents a major transplant-related 
complication initiated by host-reactive T-cells after BMT, 
and the systemic effects of this initial donor anti-host 
reaction comprise multi-organ syndrome [6]. 
CNS hemorrhage is the most prevalent autopsy finding in 
patient mortality after BMT [2]. In the case reported, an 
induction of an autoimmune-like complications following 
BMT was accompanied by severe heart failure with 
massive myocardial hemorrhage and infiltration by 
donor-derived CD8-positive cells [12]. Autoimmune-like 
complications following BMT is also associated with 
pulmonary edema and cyst formation [14], gonadotoxicity 
[16], and morphological and functional alterations of 
thymus [8]. Moreover, autoimmune-like complications 
remain one of the persistent problems of allogeneic BMT, 
mostly affecting the skin, gut and the liver [12].
In our case, a large number of infiltrating RBCs were seen 
in the cerebellar parenchymal spaces, heart, systemic 
subcutaneous, gastrointestinal tract and liver. Hemorrhage 
and atrophy of testis and thymus were also observed, and 
these findings correspond with the previous results 
mentioned above. There are several factors mentioned in 
the literature that can be associated with systemic hemorrhage 
of these multiple organs after BMT. They include a low 
platelet count or platelet refractoriness underlying BMT 
[3,15]. And humans with low WBC counts after allogeneic 
BMT had a significantly higher risk of primary failure of 
engraftment, or death due to infection, hemorrhage, or 
graft failure compared to those with higher leukocyte 
counts [11]. Moreover, it was reported that the BM 
cytology for allogeneic BM transplanted mice showed 
displastic BM features in erythroid, myeloid and 
megakaryocytic cell lineages [15]. In our case, the low 
platelet and WBC counts in peripheral blood as well as 
severe depletion of hematopoietic cell in BM were noted. 
Further studies on cytokine profiles and subsets of 
leukocytes in blood for specifying the type of autoimmunity 
may give us more information.
References
1. Armitage JO. Bone marrow transplantation. N Engl J Med 
1994, 330, 827-838.
2. Bleggi-Torres LF, de Medeiros BC, Werner B, Neto JZ, 
Loddo G, Pasquini R, de Medeiros CR. Neuropathological 
findings after bone marrow transplantation: an autopsy study 
of 180 cases. Bone Marrow Transplant 2000, 25, 301-307.
3. Bleggi-Torres LF, Werner B, Gasparetto EL, de Medeiros 
BC, Pasquini R, de Medeiros CR. Intracranial hemorrhage 
following bone marrow transplantation: an autopsy study of 
58 patients. Bone Marrow Transplant 2002, 29, 29-32.
4. Gilman AL, Kooy NW, Atkins DL, Ballas Z, Rumelhart 
S, Holida M, Lee N, Goldman F. Complete heart block in 
association with graft-versus-host disease. Bone Marrow 
Transplant 1998, 21, 85-88.
5. Graus F, Saiz A, Sierra J, Arbaiza D, Rovira M, Carreras 
E,  Tolosa  E,  Rozman  C.  Neurologic  complications  of 
autologous and allogeneic bone marrow transplantation in 
patients  with  leukemia:  a  comparative  study.  Neurology 
1996, 46, 1004-1009.
6. Hakim F, Fowler DH, Shearer GM, Gress RE. Animal 
models of acute and chronic graft-versus-host disease. Curr 
Protoc Immunol 2001, Chapter 4, Unit 4.3.
7. Haviernik P, Zhang Y, Bunting KD. Retroviral transduction 
of murine hematopoietic stem cells. Methods Mol Biol 2008, 
430, 229-241.
8. Lapp WS, Ghayur T, Mendes M, Seddik M, Seemayer 
TA. The functional and histological basis for graft-versus- 
host-induced immunosuppression. Immunol Rev 1985, 88, 
107-133.
9. Levy S, Nagler A, Okon S, Marmary Y. Parotid salivary 
gland  dysfunction  in  chronic  graft-versus-host  disease 
(cGVHD): a longitudinal study in a mouse model. Bone 
Marrow Transplant 2000, 25, 1073-1078.
10. Liao P, Toro A, Min W, Lee S, Roifman CM, Grunebaum 
E.  Lentivirus  gene  therapy  for  purine  nucleoside  phos-
phorylase deficiency. J Gene Med 2008, 10, 1282-1293.
11. Mehta J, Powles R, Singhal S, Horton C, Middleton G, 
Eisen  T,  Meller  S,  Pinkerton  CR,  Treleaven  J. E a r l y  
identification of patients at risk of death due to infections, 
hemorrhage, or graft failure after allogeneic bone marrow 
transplantation on the basis of the leukocyte counts. Bone 
Marrow Transplant 1997, 19, 349-355.
12. Platzbecker U, Klingel K, Thiede C, Freiberg-Richter J, 
Schuh D, Ehninger G, Kandolf R, Bornh-user M. Acute 
heart failure after allogeneic blood stem cell transplantation 
due to massive myocardial infiltration by cytotoxic T cells of 
donor origin. Bone Marrow Transplant 2001, 27, 107-109.
13. Räty JK, Lesch HP, Wirth T, Ylä-Herttuala S. Improving 
safety of gene therapy. Curr Drug Saf 2008, 3, 46-53.
14. Soubani  AO,  Miller  KB,  Hassoun  PM.  Pulmonary 
complications of bone marrow transplantation. Chest 1996, 
109, 1066-1077.
15. Sprangers B, Van Wijmeersch B, Luyckx A, Sagaert X, De 
Somer L, Rutgeerts O, Lenaerts C, Landuyt W, Boeckx N, 
Dubois  B,  De  Wolf-Peeters  C,  Waer  M,  Billiau  AD. 
Allogeneic bone marrow transplantation and donor lymphocyte 
infusion in a mouse model of irradiation- induced myelodysplastic/ 
myeloproliferation syndrome (MD/ MPS): evidence for a 
graft-versus-MD/MPS effect. Leukemia 2009, 23, 340-349.
16. Wagner AM, Beier K, Christen E, Holländer GA, Krenger 
W. Leydig cell injury as a consequence of an acute graft- 
versus-host reaction. Blood 2005, 105, 2988-2990.